[Recent acquisitions in antibiotic therapy].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D002228:Carbenicillin / Q000494:pharmacology; D002506:Cephalexin / Q000494:pharmacology; D002981:Clindamycin / Q000494:pharmacology; D004318:Doxycycline / Q000494:pharmacology; D005839:Gentamicins / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D013420:Sulfamethoxazole / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002981:Clindamycin; D014295:Trimethoprim; D013752:Tetracycline; D008911:Minocycline; D002228:Carbenicillin; D013420:Sulfamethoxazole; D004318:Doxycycline; D002506:Cephalexin; D012293:Rifampin
Acquisitions récentes en antibiothérapie.